…
Celsius Holdings, Inc. develops, processes, manufactures, markets, sells, and distributes functional energy drinks in the United States, North America, Europe, the Asia Pacific, and internationally. The company offers CELSIUS ESSENTIALS, a functional energy drink formulated with aminos; and CELSIUS Hydration, a line of zero-sugar hydration powders featuring electrolytes in various fruit-forward flavors, as well as ready-to-drink energy beverages, on-the-go powder and hydration sticks, and nutrition and wellness products under CELSIUS, Alani Nu, and Rockstar brand names. It distributes its products through direct-to-store delivery, independent distributors, supermarkets, convenience stores, drug stores, nutritional stores, food service providers, and mass merchants, as well as natural food stores, fitness centers, mass market retailers, vitamin specialty stores, club stores, gyms, and e-commerce platforms. The company was formerly known as Vector Ventures, Inc. and changed its name to Celsius Holdings, Inc. in January 2007. Celsius Holdings, Inc. was founded in 2004 and is headquartered in Boca Raton, Florida.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Celsius Holdings, Inc. makes and sells fitness-oriented, zero-sugar energy drinks and related functional beverages aimed at active consumers. Long-term growth may be supported by expanded retail and international distribution, product innovation, marketing partnerships and greater direct-to-consumer penetration, which could support revenue expansion and make the brand attractive to investors.
Material risks include intense competition from large beverage companies and private labels, execution risk in scaling distribution and marketing, supply-chain and ingredient-cost pressures, and potential regulatory scrutiny of ingredient claims.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 125.03M | 195.05M | 291.75M | -152.66M | -4.06M |
| Net income | 108.00M | 145.07M | 226.80M | -187.28M | 3.94M |
| Selling general administrative | 798.81M | 515.86M | 203.67M | 75.90M | 57.52M |
| Selling and marketing expenses | - | 0.22M | 160.00M | 352.77M | 74.74M |
| Gross profit | 1267.33M | 680.21M | 633.14M | 270.87M | 128.17M |
| Reconciled depreciation | 29.45M | 7.27M | 2.68M | 1.92M | 1.26M |
| Ebit | 174.01M | 155.73M | 266.37M | -157.80M | -4.09M |
| Ebitda | 203.46M | 163.00M | 269.59M | -150.35M | -2.51M |
| Depreciation and amortization | 29.45M | 7.27M | 3.23M | 7.45M | 1.58M |
| Non operating income net other | - | - | - | -0.15M | 0.03M |
| Operating income | 468.52M | 155.73M | 266.37M | -157.80M | -4.09M |
| Other operating expenses | 2046.75M | 1199.90M | 1051.65M | 811.40M | 318.36M |
| Interest expense | 48.98M | 0.00M | 26.50M | 5.29M | 0.01M |
| Tax provision | 17.03M | 49.98M | 40.24M | 34.62M | -8.00M |
| Interest income | 21.09M | 39.26M | 21.72M | 5.53M | 0.31M |
| Net interest income | -27.89M | 39.26M | 21.72M | 5.53M | 0.31M |
| Income tax expense | 17.03M | 49.98M | 64.95M | 34.62M | -8.00M |
| Total revenue | 2515.27M | 1355.63M | 1318.01M | 653.60M | 314.27M |
| Total operating expenses | 798.81M | 524.48M | 366.77M | 428.67M | 132.26M |
| Cost of revenue | 1247.94M | 675.42M | 684.88M | 382.74M | 186.10M |
| Total other income expense net | -343.49M | 39.32M | 25.38M | 5.14M | 0.03M |
| Net income from continuing ops | 108.00M | 145.07M | 155.46M | -187.28M | 3.94M |
| Net income applicable to common shares | - | - | - | -198.81M | 3.94M |
| Preferred stock and other adjustments | - | - | - | 11.53M | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 5119.62M | 1766.88M | 1536.40M | 1222.07M | 314.02M |
| Intangible assets | 1391.91M | 12.21M | 12.14M | 12.25M | 16.30M |
| Other current assets | 319.09M | 32.88M | 19.50M | 11.34M | 13.56M |
| Total liab | 2178.18M | 542.46M | 447.87M | 357.49M | 96.97M |
| Total stockholder equity | 2941.44M | 1224.42M | 1088.53M | 864.58M | 217.05M |
| Deferred long term liab | - | - | - | 15.92M | 3.15M |
| Other current liab | 864.20M | 286.78M | 223.22M | 105.97M | 51.20M |
| Common stock | 0.10M | 0.08M | 0.08M | 0.08M | 0.07M |
| Capital stock | 1760.08M | 824.57M | 824.57M | 824.56M | 0.07M |
| Retained earnings | 175.91M | 105.52M | -12.05M | -238.77M | -51.49M |
| Other liab | - | - | - | 195.71M | 3.15M |
| Good will | 917.56M | 71.58M | 14.17M | 13.68M | 14.53M |
| Other assets | - | -14.12M | - | 266.80M | 16.44M |
| Cash | 398.87M | 890.19M | 755.98M | 614.16M | 16.25M |
| Total current liabilities | 1078.73M | 365.54M | 276.61M | 161.29M | 93.12M |
| Current deferred revenue | 26.99M | 23.27M | 9.51M | 18.35M | 5.44M |
| Net debt | 271.06M | -869.94M | -753.79M | -612.94M | -14.88M |
| Short term debt | - | 3.37M | 1.04M | 0.73M | 0.67M |
| Short long term debt total | 669.93M | 20.25M | 2.19M | 1.22M | 1.37M |
| Other stockholder equity | 1002.29M | 297.58M | 276.72M | 280.67M | 267.85M |
| Property plant equipment | - | - | - | 10.19M | 4.39M |
| Total current assets | 1811.15M | 1324.58M | 1190.78M | 917.97M | 262.36M |
| Long term investments | - | - | - | 3.57M | 7.12M |
| Net tangible assets | - | - | - | 14.16M | 186.22M |
| Net receivables | 755.50M | 270.34M | 186.02M | 66.29M | 41.33M |
| Long term debt | 669.93M | - | - | - | - |
| Inventory | 337.70M | 131.16M | 229.28M | 173.29M | 191.22M |
| Accounts payable | 137.93M | 41.29M | 42.84M | 36.25M | 35.82M |
| Accumulated other comprehensive income | 3.16M | -3.25M | -0.70M | -1.88M | 0.61M |
| Common stock total equity | - | - | - | 0.08M | 0.07M |
| Preferred stock total equity | - | - | - | 824.49M | - |
| Retained earnings total equity | - | - | - | -238.77M | -51.49M |
| Non currrent assets other | 815.07M | 242.37M | 262.75M | 266.30M | 7.42M |
| Non current assets total | 3308.47M | 442.30M | 345.62M | 304.10M | 51.66M |
| Capital lease obligations | - | 20.25M | 2.19M | 1.22M | 1.37M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -10.00M | -101.73M | -14.24M | 2.59M | 1.89M |
| Change to liabilities | - | - | - | 226.98M | 65.56M |
| Total cashflows from investing activities | -1295.68M | -101.73M | -14.20M | -5.67M | -1.26M |
| Net borrowings | 698.25M | -0.06M | -0.04M | -0.06M | -0.09M |
| Total cash from financing activities | 582.76M | -25.97M | -25.22M | 534.11M | 71.40M |
| Change to operating activities | - | - | - | 25.60M | 1.47M |
| Net income | 108.00M | 145.07M | 226.80M | -187.28M | 3.94M |
| Change in cash | -350.20M | 134.21M | 103.05M | 636.67M | -26.99M |
| Begin period cash flow | 890.19M | 755.98M | 652.93M | 16.25M | 43.25M |
| End period cash flow | 539.99M | 890.19M | 755.98M | 652.93M | 16.25M |
| Total cash from operating activities | 359.44M | 262.90M | 141.22M | 108.18M | -96.59M |
| Issuance of capital stock | - | 0.00M | 0.00M | 542.02M | 67.77M |
| Depreciation | 29.45M | 7.27M | 3.23M | 1.92M | 1.26M |
| Other cashflows from investing activities | 29.16M | - | 3.23M | 2.59M | 1.89M |
| Dividends paid | 37.61M | 27.50M | 27.46M | -11.53M | 11.53M |
| Change to inventory | -129.78M | 77.19M | -63.30M | 11.80M | -175.17M |
| Change to account receivables | -412.09M | -87.35M | -121.56M | -26.37M | -25.25M |
| Sale purchase of stock | -39.78M | -2.26M | -2.29M | 545.70M | 3.72M |
| Other cashflows from financing activities | -5.73M | 3.86M | 2.29M | 542.02M | 3.72M |
| Change to netincome | - | - | - | 25.88M | 37.09M |
| Capital expenditures | 36.07M | 23.39M | 17.43M | 8.26M | 3.15M |
| Change receivables | - | - | - | -26.37M | -25.25M |
| Cash flows other operating | - | - | - | 55.25M | -5.77M |
| Exchange rate changes | - | - | - | - | -0.54M |
| Cash and cash equivalents changes | - | - | - | 636.62M | -26.99M |
| Change in working capital | 167.05M | 62.60M | -92.99M | 235.41M | -133.94M |
| Stock based compensation | 28.05M | 19.59M | 21.23M | 20.66M | 36.48M |
| Other non cash items | 26.90M | 38.09M | 25.01M | 17.23M | 4.70M |
| Free cash flow | 323.38M | 239.51M | 123.78M | 99.92M | -99.74M |
Sector: Consumer Defensive Industry: Beverages - Non-Alcoholic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CELH Celsius Holdings Inc |
2.12 7.06% |
32.16 | 125.59 | 16.45 | 2.29 | 6.00 | 2.95 | 38.62 |
| KO The Coca-Cola Company |
0.05 0.05% |
95.78 | 23.61 | 20.58 | 5.53 | 9.46 | 6.08 | 17.61 |
| PEP PepsiCo Inc |
-1.37 0.96% |
141.34 | 26.80 | 20.62 | 2.53 | 12.49 | 2.90 | 16.87 |
| MNST Monster Beverage Corp |
-2.11 4.41% |
45.72 | 41.32 | 33.90 | 9.48 | 9.25 | 9.21 | 30.01 |
| NNFSF Nongfu Spring Co. Ltd |
- -% |
5.26 | 24.81 | 20.04 | 1.03 | 9.96 | 7.00 | 15.10 |
Celsius Holdings, Inc. develops, processes, manufactures, markets, sells, and distributes functional energy drinks in the United States, North America, Europe, the Asia Pacific, and internationally. The company offers CELSIUS ESSENTIALS, a functional energy drink formulated with aminos; and CELSIUS Hydration, a line of zero-sugar hydration powders featuring electrolytes in various fruit-forward flavors, as well as ready-to-drink energy beverages, on-the-go powder and hydration sticks, and nutrition and wellness products under CELSIUS, Alani Nu, and Rockstar brand names. It distributes its products through direct-to-store delivery, independent distributors, supermarkets, convenience stores, drug stores, nutritional stores, food service providers, and mass merchants, as well as natural food stores, fitness centers, mass market retailers, vitamin specialty stores, club stores, gyms, and e-commerce platforms. The company was formerly known as Vector Ventures, Inc. and changed its name to Celsius Holdings, Inc. in January 2007. Celsius Holdings, Inc. was founded in 2004 and is headquartered in Boca Raton, Florida.
2381 NW Executive Center Drive, Boca Raton, FL, United States, 33431
561 276 2239
1497
| Name | Title | Year Born |
|---|---|---|
| Mr. John Fieldly | Pres, CEO & Chairman | 1980 |
| Mr. Edwin F. Negron-Carballo | Exec. Officer | 1962 |
| Mr. Jarrod Langhans | Chief Financial Officer | 1981 |
| Ms. Sandy Telsaint | VP of Operations | NA |
| Mr. Paul Storey | Sr. VP of Operations | NA |
| Mr. Cameron Donahue | Investor Relations | NA |
| Mr. Marcus Sandifer | VP of Bus. & Legal Affairs, Gen. Counsel and Corp. Sec. | NA |
| Ms. Kyle Watson | VP of Marketing | NA |
| Mr. Jon McKillop | Exec. VP of Sales for North America | NA |
| Mr. Ronnie Char | Managing Director of Asia | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.